Resolys Bio
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
545 Westfall Rd, Delanson, New York, 120...Phone Number
(518) 872-1144Website
www.resolysbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Resolys Bio
Resolys Bio, Inc. is a privately held pharmaceutical company based in Delanson, NY, that specializes in two innovative products: oxidized streptolysin O (oSLO) for chronic traumatic brain injury and a proprietary multi-component compound (MCC) for hypermobile Ehlers Danlos Syndrome. The company aims to address medical conditions that currently lack FDA-approved treatments, particularly targeting the ongoing cognitive and physical deficits experienced by individuals with chronic TBI and alleviating pain in those with hEDS. With a leadership team comprising seasoned biotech professionals, Resolys Bio is committed to making significant advancements in effective therapies for these conditions. The estimated market potential for these products indicates a vast number of individuals in need, representing significant opportunities for impactful medical solutions.Explore more
Resolys Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Resolys Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Resolys Bio has new funding data
Resolys Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Resolys Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Resolys Bio launches new products
Click to see if Resolys Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Resolys Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Resolys Bio
Check if Resolys Bio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Resolys Bio
Compare insights from companies similar to Resolys Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Resolys Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Resolys Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Resolys Bio.
Resolys Bio Tech Stack
A closer look at the technologies used by Resolys Bio
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Resolys Bio
Sign Up For FreeTo access detailed company insights
Resolys Bio, Inc. is a privately held pharmaceutical company based in Delanson, NY, that specializes in two innovative products: oxidized streptolysin O (oSLO) for chronic traumatic brain injury and a proprietary multi-component compound (MCC) for hypermobile Ehlers Danlos Syndrome. The company aims to address medical conditions that currently lack... Read More
